Cargando…

Effects of Enalapril on TLR2/NF-κB Signaling Pathway and Inflammatory Factors in Rabbits with Chronic Heart Failure

Chronic heart failure (CHF) refers to the state of persistent heart failure, which is a complex clinical syndrome of various advanced heart diseases. The toll-like receptor 2 (TLR2)/nuclear transcription factor-κB (NF-κB) signal transduction pathway is one of the pathological mechanisms of CHF. Adri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yanping, Xu, Zelin, Chen, Xinyu, Wang, Nan, Deng, Xu, Peng, Liqi, Chen, Qingyang, Cai, Huzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294953/ https://www.ncbi.nlm.nih.gov/pubmed/34335842 http://dx.doi.org/10.1155/2021/9594607

Ejemplares similares

Effects of the Wenyang Zhenshuai Granule on the Expression of LncRNA-MiR143HG/miR-143 Regulating ERK5 in H9C2 Cardiomyocytes
por: Xu, Zelin, et al.
Publicado: (2021)

Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies)
por: Laeer, Stephanie, et al.
Publicado: (2022)

Comparison of Sacubitril/Valsartan Versus Enalapril in the Management of Heart Failure
por: Bano, Shehar, et al.
Publicado: (2021)

Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran
por: Ravangard, Ramin, et al.
Publicado: (2023)

Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins
por: Yang, Yushan, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared to Enalapril for Heart Failure Patients in Indonesia
por: Zakiyah, Neily, et al.
Publicado: (2021)

Rhoifolin Alleviates Alcoholic Liver Disease In Vivo and In Vitro via Inhibition of the TLR4/NF-κB Signaling Pathway
por: Mai, Baoyu, et al.
Publicado: (2022)

Sacubitril-Valsartan Compared With Enalapril for the Treatment of Heart Failure: A Decision-Analytic Markov Model Simulation in China
por: Wu, Yue, et al.
Publicado: (2020)

Thalidomide Alleviates Pulmonary Fibrosis Induced by Silica in Mice by Inhibiting ER Stress and the TLR4-NF-κB Pathway
por: Li, Yaqian, et al.
Publicado: (2022)

rhHMGB1 drives osteoblast migration in a TLR2/TLR4- and NF-κB-dependent manner
por: Li, Ming-Jing, et al.
Publicado: (2016)

The effect of focal cerebral ischemia-reperfusion injury on TLR4 and NF-κB signaling pathway
por: Chen, Jing, et al.
Publicado: (2018)

Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
por: Morrow, David A, et al.
Publicado: (2019)

Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial
por: Bhatt, Ankeet S., et al.
Publicado: (2021)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Antioxidant Effect of Captopril and Enalapril on Reactive Oxygen Species-Induced Endothelial Dysfunction in the Rabbit Abdominal Aorta
por: Kim, Ji Hoon, et al.
Publicado: (2013)

NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
por: Maeda, Shin
Publicado: (2010)

Effect of Valsartan on N-Terminal Pro-Brain Natriuretic Peptide in Patient With Stable Chronic Heart Failure: Comparison With Enalapril
por: Lee, Young Soo, et al.
Publicado: (2011)

The comparative effects of sacubitril/valsartan versus enalapril on pulmonary hypertension due to heart failure with a reduced ejection fraction
por: Zhao, Ying, et al.
Publicado: (2022)

Safety and efficacy of ARNI (valsartan/sacubitril) vs ACEI (enalapril) in acute heart failure – A prospective observational study
por: Bhat, Tahir Saleem, et al.
Publicado: (2022)

Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis
por: Hu, Tianyang, et al.
Publicado: (2023)

Cost-Effectiveness of Sacubitril/Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction: A Systematic Review
por: Rezapour, Aziz, et al.
Publicado: (2022)

Importance of extra- and intracellular domains of TLR1 and TLR2 in NFκB signaling
por: Sandor, Frantisek, et al.
Publicado: (2003)

Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction
por: Chai, Ruoning, et al.
Publicado: (2023)

The Role of bFGF in the Excessive Activation of Astrocytes Is Related to the Inhibition of TLR4/NFκB Signals
por: Ye, Libing, et al.
Publicado: (2015)

Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study
por: Pathadka, Swathi, et al.
Publicado: (2021)

Effects of Angiotensin Receptor-Neprilysin Inhibitors Versus Enalapril or Valsartan on Patients With Heart Failure: A Systematic Review and Meta-Analysis
por: Jain, Arpit, et al.
Publicado: (2023)

Expression of TLR4-MyD88 and NF-κB in the Iris during Endotoxin-Induced Uveitis
por: Li, Shang, et al.
Publicado: (2010)

Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF-κB signaling pathway
por: Wan, Chun-Xia, et al.
Publicado: (2018)

TLR7 promotes skin inflammation via activating NFκB-mTORC1 axis in rosacea
por: Huang, Yaqun, et al.
Publicado: (2023)

Modulation of TLR4/NFκB Pathways in Autoimmune Myocarditis
por: Interdonato, Livia, et al.
Publicado: (2023)

Nuclear Factor (NF) κB polymorphism is associated with heart function in patients with heart failure
por: Santos, Diogo GB, et al.
Publicado: (2010)

Polyguanine alleviated autoimmune hepatitis through regulation of macrophage receptor with collagenous structure and TLR4‐TRIF‐NF‐κB signalling
por: Cai, Tingchen, et al.
Publicado: (2022)

Qishen Granule (QSG) Inhibits Monocytes Released From the Spleen and Protect Myocardial Function via the TLR4-MyD88-NF-κB p65 Pathway in Heart Failure Mice
por: Li, Yanqin, et al.
Publicado: (2022)

MG53 suppresses NF-κB activation to mitigate age-related heart failure
por: Wang, Xiaoliang, et al.
Publicado: (2021)

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial
por: Vardeny, Orly, et al.
Publicado: (2016)

Berberine attenuates septic cardiomyopathy by inhibiting TLR4/NF-κB signalling in rats
por: Chen, Huiqi, et al.
Publicado: (2021)

Inflammatory extracellular vesicles prompt heart dysfunction via TLR4-dependent NF-κB activation: Erratum
por: Biemmi, Vanessa, et al.
Publicado: (2023)

Hemodynamic and mitochondrial effects of enalapril in experimental sepsis
por: Pereira, AJ, et al.
Publicado: (2013)

Efficacy of Topical Enalapril in Treatment of Hypertrophic Scars
por: Mohammadi, Ali Akbar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bljsscnobd6331hu7rji9rj2f6